A Comparison of Inpatient Cost Per Day in General Surgery Patients with Type 2 Diabetes Treated with Basal-Bolus versus Sliding Scale Insulin Regimens
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The identification of cost-effective glycaemic management strategies is critical to hospitals. Treatment with a basal-bolus insulin (BBI) regimen has been shown to result in better glycaemic control and fewer complications than sliding scale regular insulin (SSI) in general surgery patients with type 2 diabetes mellitus (T2DM), but the effect on costs is unknown. OBJECTIVE: = 99) regimens. METHODS: Data were collected from patient clinical and hospital billing records. Charges were adjusted to reflect hospital costs. General linearized models were used to estimate the risk-adjusted effects of BBI versus SSI treatment on average total inpatient costs per day. RESULTS: Risk-adjusted average total inpatient costs per day were $US5404. Treatment with BBI compared with SSI reduced average total inpatient costs per day by $US751 (14%; 95% confidence interval [CI] 20-4). Being treated in a university medical centre, being African American or having a bowel procedure or higher-volume pharmacy use significantly reduced costs per day. CONCLUSIONS: In general surgery patients with T2DM, a BBI regimen significantly reduced average total hospital costs per day compared with an SSI regimen. BBI has been shown to improve outcomes in a randomized controlled trial. Those results, combined with our findings regarding savings, suggest that hospitals should consider adopting BBI regimens in patients with T2DM undergoing surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“RCTs have shown that treatment with a basal prandial regimen using insulin analogs improved glycemic control with fewer hospital complications in general medical and surgical persons with T2D compared with sliding-scale regular insulin alone.92,107,108,1333–1336”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [107]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Overall, studies have shown that treatment including a basal insulin regimen resulted in better glycemic control compared with sliding-scale insulin alone.92,107–109”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [107]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Several studies have compared different basal insulin formulations, including glargine U100, insulin detemir U100, glargine U300, and degludec U100, with similar glycemic control results.92,107,1343–1346”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [107]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Association of American Medical Colleges
Zapffe, F. C. (1938) · Academic Medicine · doi:10.1097/00001888-193801000-00007 · Cited by 5,533
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationMoghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444 · cited 1×
“Current clinical guidelines now recommend the use of BBI in general surgery patients specifically to help manage diabetes and hyperglycaemia [20, 21].”
BackgroundSelf-citationFurnary, A. P., Zerr, K. J., Grunkemeier, G. L., & Starr, A. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00014-4 · Cited by 1,230 · cited 1×
“rates of multi-organ system failure [4], infection [5, 6] and”
BackgroundUmpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126 · cited 1×
“Current clinical guidelines now recommend the use of BBI in general surgery patients specifically to help manage diabetes and hyperglycaemia [20, 21].”
BackgroundSelf-citationUmpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011) · Diabetes Care · doi:10.2337/dc10-1407 · Cited by 720 · cited 2×
“Glycaemic control management programmes have been shown to reduce the occurrence of these events [10] and hospital costs in both critical care and cardiac patients [4, 11–13].”
BackgroundSelf-citationEarly Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700 · cited 1×
“rates of multi-organ system failure [4], infection [5, 6] and”
BackgroundUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationKosiborod, M., Rathore, S. S., Inzucchi, S. E., Masoudi, F. A., Wang, Y., Havranek, E. P., & Krumholz, H. M. (2005) · Circulation · doi:10.1161/circulationaha.104.517839 · Cited by 666
Prevention effectiveness : a guide to decision analysis and economic evaluation
Haddix, A. C. (1996) · Cited by 576
Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis
Falciglia, M., Freyberg, R. W., Almenoff, P. L., D’Alessio, D. A., & Render, M. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b083f7 · Cited by 576
Baker, E. H. (2006) · Thorax · doi:10.1136/thx.2005.051029 · Cited by 418 · cited 1×
“Observational studies and randomized controlled trials (RCTs) have documented that hyperglycaemia and diabetes are associated with poor outcomes in hospital patients [2, 3], including increased & Victoria L.”
BackgroundLength of stay has minimal impact on the cost of hospital admission1
Taheri, P. A., Butz, D. A., & Greenfield, L. J. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00352-5 · Cited by 351 · cited 1×
“Statistical analyses were performed using SPSS (v23) [33].”
MethodEstrada, C. A., Young, J. A., Wiley Nifong, L., & Chitwood, W. R. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04997-4 · Cited by 277 · cited 1×
“Observational studies and randomized controlled trials (RCTs) have documented that hyperglycaemia and diabetes are associated with poor outcomes in hospital patients [2, 3], including increased & Victoria L.”
BackgroundVan den Berghe, G., Wouters, P. J., Kesteloot, K., & Hilleman, D. E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201408.15502.24 · Cited by 201 · cited 1×
“rates of multi-organ system failure [4], infection [5, 6] and”
BackgroundCost Analysis of Intensive Glycemic Control in Critically Ill Adult Patients
Stephen Krinsley, J., & Jones, R. L. (2006) · Chest · doi:10.1378/chest.129.3.644 · Cited by 185 · cited 1×
“These interventions are very inexpensive, which is critical; one study reported net savings of $US1885 per day from an ICU management programme [11].”
BackgroundFinancial Implications of Glycemic Control: Results of An Inpatient Diabetes Management Program
Newton, C. A., & Young, S. L. (2006) · Endocrine Practice · doi:10.4158/ep.12.s3.43 · Cited by 103 · cited 1×
“Our findings are in accord with other analyses of glycaemic management programmes in that we found decreased costs [12, 13].”
ResultDiabetes mellitus and cardiothoracic surgical site infections
Talbot, T. R. (2005) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.008 · Cited by 73 · cited 1×
“As patients with diabetes are at increased risk for both, improved clinical management of this group is increasingly important [15].”
BackgroundDirect medical costs for type 2 diabetes mellitus complications in the US commercial payer setting
Pelletier, E. M., Smith, P., Boye, K. S., Misurski, D. A., Tunis, S. L., & Minshall, M. E. (2008) · Applied Health Economics and Health Policy · doi:10.1007/bf03256126 · Cited by 61
Griswold, M., & Parmigiani, G. (2004) · Cited by 48
Rybicki, B. A., Johnson, C. C., Peterson, E. L., Kortsha, G. X., & Gorell, J. M. (1997) · American Journal of Industrial Medicine · doi:10.1002/(sici)1097-0274(199701)31:1<50::aid-ajim8>3.0.co;2-0 · Cited by 47
Focus group data as a tool in assessing effectiveness of a hand hygiene campaign
Thomas, M., Gillespie, W. A., Krauss, J., Harrison, S., Medeiros, R. S., Hawkins, M. L., Maclean, R., & Woeltje, K. F. (2005) · American Journal of Infection Control · doi:10.1016/j.ajic.2005.03.011 · Cited by 47
Care resource utilization and direct costs incurred by people with diabetes in a Spanish hospital
Carral, F., Olveira, G., Salas, J. C., Garcı́a, L., Sillero, Á., & Aguilar‐Diosdado, M. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00342-4 · Cited by 43 · cited 1×
“In this environment, patients with poorly managed diabetes present a substantial liability as they are known to generally have more costly inpatient stays than those without the condition [18].”
BackgroundEconomic Benefits of Intensive Insulin Therapy in Critically Ill Patients
Sadhu, A., Ang, A. C., Ingram-Drake, L. A., Martinez, D. S., Hsueh, W. A., & Ettner, S. L. (2008) · Diabetes Care · doi:10.2337/dc07-2456 · Cited by 34 · cited 1×
“Our findings are in accord with other analyses of glycaemic management programmes in that we found decreased costs [12, 13].”
Result
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationRecent advances in diabetes treatments and their perioperative implications
Kuzulugil, D., Papeix, G., Luu, J., & Kerridge, R. K. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000735 · Cited by 52
Ekanayake, P. S., Juang, P. S., & Kulasa, K. M. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01364-2 · Cited by 21
Newsom, R., Patty, C. M., Camarena, E., Sawyer, R., McFarland, R., Gray, T. L., & Mabrey, M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817747619 · Cited by 22
“Numerous publications have demonstrated SSI has no benefits to glycemic control.(10-12) A recent meta-analysis demonstrated no benefit in glycemic control with the use of SSI yet higher rates of hyperglycemia.”
BackgroundExploring Trajectories of Health Care Utilization Before and After Surgery
Graham, L. A., Wagner, T. H., Richman, J., Morris, M. S., Copeland, L. A., Harris, A. H. S., Itani, K. M. F., & Hawn, M. T. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.10.010 · Cited by 16
Metadata
- Authors
- Phillips, V. L., Byrd, A. L., Adeel, S., Peng, L., Smiley, D. D., & Umpierrez, G. E.
- Affiliations
- Emory University (US)
- Corresponding author
- Phillips, Victoria L.
- Venue
- PharmacoEconomics - Open
- Published
- 2017-04-21
- Volume
- 1
- Issue
- 2
- Pages
- 109-115
- ISSN
- 2509-4254 (ISSN-L)
- 2509-4262
- PMC
- PMC5468101
- OpenAlex
- W2607050128
- Cited by
- 13
- References
- 24
- Citations by year
- 2025: 2 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PharmacoEconomics - Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, sliding scale insulin, inpatient hospital costs, general surgery patients, cost-effectiveness, risk adjustment, African American patients, intestinal surgery, pharmacy utilization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.